MDM2 inhibitor
Concentra makes a bid to buy Rain Oncology, a struggling biotech with two cancer drugs
Anika Sharma
Concentra Biosciences, having weathered a failed acquisition of Atea Pharmaceuticals earlier this year, has now turned its attention to Rain ...
